throbber
on June 20, 2016
`
`http://science.sciencemag.org/
`
`Downloaded from
`
`beled at the 5' end were purified by Sephadex G-
`50 chromatography in a 0.3M sodium acetate,
`0.OlM tris-HCI, pH 7.9, 0.001M EDTA system,
`and concentrated by precipitation with ethanol.
`6. A. Maxam and W. Gilbert, Proc. Natl. Acad.
`Sci. U.S.A. 74, 560 (1977).
`7. Low molecular weight DNA fragments were re-
`solved by electrophoresis at < 10 volt/cm in gels
`containing 10 percent polyacrylamide (acryla-
`N,N'-methylenebisacrylamide = 25: 1)
`mide:
`in one-half strength TBE [0.05M tris-borate, pH
`8.3, 0.001M EDTA, A. Peacock and C. Ding-
`man, Biochemistry 7, 668 (1968)] with 25 percent
`glycerol. Glycerol improves band sharpness dra-
`matically.
`8. J. Dahlberg and F. Blattner, in Virus Research,
`C. Fox and W. Robinson, Eds. (Academic
`Press, New York, 1973), p. 533.
`9. M. Rosenberg, personal communication.
`10. D. Kleid, Z. Humayun, A. Jeffrey, M. Ptashne,
`Proc. Natl. Acad. Sci. U.S.A. 73, 293 (1976).
`11. M. Rosenberg, B. de Crombrugghe, R. Musso,
`ibid., p. 717.
`12. G. Scherer, G. Hobom, H. Kossel, Nature
`(London) 256, 117 (1977).
`13. V. Pirotta, personal communication.
`14. E. Schwarz, G. Scherer, G. Hobom, H. K6ssel,
`personal communication.
`14a.G. Scherer, G. Hobom, H. Kossel, personal
`communication.
`15. B. Westmoreland, W. Szybalski, H. Ris, Sci-
`ence 163, 1343 (1969).
`16. D. Hewish, K. Smith, J. Spencer, Virology 74,
`363 (1976).
`17. A. Rambach, ibid. 54, 270 (1973).
`18. W. Dove, H. Inokuchi, W. Stevens, in The Bac-
`teriophage Lambda, A. D. Hershey, Ed. (Cold
`Spring Harbor Laboratory, Cold Spring Harbor,
`N.Y., 1971), p. 747.
`19. W. Szybalski et al., J. Cell. Physiol. 74 (Suppl.
`1), 33 (1969).
`20. H. Inokuchi, W. Dove, D. Freifelder, J. Mol.
`Biol. 74, 721 (1973).
`21. N. Kleckner, Virology 79, 174 (1977).
`22. M. Schnos and R. Inman, J. Mol. Biol. 55, 31
`(1971); A. Kozinski and B. Lindqvist, personal
`communication.
`23. The X ori region, defined by the ori- mutations,
`has two dPy - dPu stretches (18 bp and 18 of 21
`bp) in which the pyrimidines are on the r strand.
`The origin of Col El replication, defined by the
`site at which deoxyribonucleotides are added
`onto an RNA primer in vitro, is 20 bp away from
`a dPy - dPu stretch (21 of 24 bp) with purines on
`the transcribed strand [J.-I. Tomizawa, H. Oh-
`mori, R. Bird, Proc. Natl. Acad. Sci. U.S.A. 74,
`1865 (1976)]. The origin region for phage fd
`DNA replication, defined by an in virto RNA
`primer, contains a dPy * dPu stretch (29 of 32
`bp) with pyrimidines on the transcribed strand
`(C. Gray, R. Sommer, C. Polke, E. Beck, H.
`Schaller, personal communication). The pyrimi-
`dine tract CTC5 lies in the region of the A gene
`dependent gap in OX174 at the start of RF to RF
`replication [S. Eisenberg, B. Harbers, C. Hours,
`D. Denhardt, J. Mol. Biol. 99, 197 (1975)].
`24. F. Sanger, G. Air, B. Barrell, N. Brown, A.
`Coulson, J. Fiddes, C. Hutchison, P. Slocombe,
`M. Smith, Nature (London) 265, 687 (1977); P.
`Baas, H. Jansz, R. Sinsheimer, J. Mol. Biol.
`102, 633 (1976); S. Eisenberg, B. Harbers, C.
`liours, D. Denhardt, ibid. 99, 197 (1975).
`25. R. Fisher, The Genetical Theory of Natural Se-
`lection (Clarendon, Oxford, 1930).
`26. We believe that the deletions observed in the nu-
`cleotide sequences for r93, r99, and r96 corre-
`spond to the orti lesions. The ori- mutants were
`isolated without mutagenesis and occur with fre-
`quencies inconsistent with multiple mutations.
`The deletions could not have arisen during clon-
`ing, because they are present in the ori- phages
`ANam7NamS3cI8S7r93
`ANam7NarnS3c-
`and
`1857r99. The 0 protein made from the DNA of
`these phages in vitro is smaller than that made
`from DNA of the oril parent phage when mea-
`by SDS polyacrylamide
`sured
`gel
`elec-
`trophoresis (J. Yates and M. Furth, unpublished
`results, using techniques described in J. Yates,
`W. Gette, M. Furth, M. Nomura, Proc. Natl.
`Acad. Sci. U.S.A. 74, 689 (1977)]. The size of
`each deletion is consistent with the changes in
`molecular weights of the 0 protein made in vitro
`and of DNA restriction fragments. Finally, the
`recombinational map of the ori- mutations is
`consistent with the order of the sequenced dele-
`tions (r93-r99-r96), indicating that the deletions
`are responsible for the ori- pheonotype of these
`mutants (2).
`27. J. Szpirer, Mol. Gen. Genet. 114, 297 (1972); M.
`Furth, C. McLeester, W. Dove, in preparation;
`L. Lambert, R. Thomas, R. Monnat, W. Szy-
`balski, personal communication.
`28. By the criterion of heteroduplex pairing, the re-
`1056
`
`gion of DNA encoding the COOH-terminal half
`of the 0 protein appears to be lar%ely conserved
`in all five lamboid coliphages studied [M. Simon,
`R. Davis, N. Davidson, in The Bacteriophage
`Lambda, A. D. Hershey, Ed. (Cold Spring Har-
`bor Laboratory, Cold Spring Harbor, N.Y.,
`1971), p. 313; M. Fiandt, Z. Hradecna, H. Loze-
`ron, W. Szybalski,
`ibid.,
`p.
`329]. Com-
`plementation analysis shows that P gene func-
`tion can be provided to X by each of the other
`four lamboid phages [W. Dove, Annu. Rev.
`Genet. 2, 305 (1969); J. Szpirer and P. Brachet,
`Mol. Gen. Genet. 108, 78 (1970)]. In 4+80/A hy-
`brid phages such as Ximm80hy42 the 0 gene (27)
`and 0 protein iteself have been shown to be hy-
`brid (J. Yates and M. Furth, unpublished obser-
`vations). There is genetic evidence for direct in-
`teraction between 0 and P proteins [J.-I. Tomi-
`zawa, in The Bacteriophage Lambda, A. D.
`Hershey, Ed. (Cold Spring Harbor Laboratory,
`Cold Spring Harbor, N.Y., 1971), p. 549; M.
`Furth, C. McLeester, W. Dove, in preparation;
`(2)] and between P protein and the E. coli repli-
`cation apparatus [C. Georgopoulos and I. Her-
`skowitz, in The Bacteriophage Lambda, A. D.
`Hershey, Ed. (Cold Spring Harbor Laboratory,
`Cold Spring Harbor, N.Y., 1971), p. 553; H.
`Saito and H. Uchida, J. Mol. Biol.
`113, 1
`(1977)].
`29. S. Hayes and W. Szybalski, in DNA Synthesis
`
`and Its Regulation, M. Goulian, P. Hanawalt,
`C. Fox, Eds. (Benjamin, Menlo Park, Calif.,
`1975), p. 486.
`30. B. Williams, M. Furth, K. Kruger, D. Moore,
`K. Denniston-Thompson, F. Blattner, in prepa-
`ration.
`30a.W. Dove, E. Hargrove, M. Ohashi, F. Haugii,
`A. Guha, Jpn. J. Genet. 44 (Suppl. 1), 11 (1969).
`31. H. Nijkamp, W. Szybalski, M. Ohashi, W.
`Dove, Mol. Gen. Genet. 114, 80 (1971).
`32. This is paper 2172 from the Laboratory of Ge-
`netics of the University of Wisconsin and paper
`No. 7 in the series "Charon phages for DNA
`Cloning." Paper No. 6 is (2). Supported by NIH
`grpsnt GM21812 to F.R.B., NIH grant CA-07175
`to McArdle Laboratory (W. F. Dove), an NSF
`predoctoral fellowship and an NIH training
`grant to McArdle Laboratory (M.E.F.), NIH
`training grant T32 CA09075 (K.D.-T.), and NIH
`training grant 144-J825 (D.D.M.). We thank W.
`F. Dove for support and advice, Nigel Godsen
`for critical reading of the manuscript, Ed Ko-
`petsky and Brenda Dierschke for technical as-
`sistance, R. Roberts for hospitality in his labora-
`tory, A. Maxam for providing the detailed se-
`quencing procedures and A. Honigman for dis-
`cussions concerning AvaX. This work was done
`under NIH guidelines, which call for EKI, P1.
`19 July 1977; revised 20 September 1977
`
`Expression in Escherichia coli of a Chemically Synthesized
`Gene for the Hormone Somatostatin
`Abstract. A gene for somatostatin, a mammalian peptide (14 amino acid residues)
`hormone, was synthesized by chemical methods. This gene was fused to the Esche-
`richia coli f3-galactosidase gene on the plasmid pBR322. Transformation of E. coli
`with the chimeric plasmid DNA led to the synthesis of a polypeptide including the
`sequence of amino acids corresponding to somatostatin. In vitro, active somatosta-
`tin was specifically cleaved from the large chimeric protein by treatment with cy-
`anogen bromide. This represents thefirst synthesis of a functional polypeptide prod-
`uct from a gene of chemically synthesized origin.
`
`The chemical synthesis of DNA and
`recombinant DNA methods provide the
`technology for the design and synthesis
`of genes that can be fused to plasmid ele-
`ments for expression in Escherichia coli
`or other bacteria. As a model system we
`have designed and synthesized a gene for
`the small polypeptide hormone, soma-
`tostatin (Figs. I and 2). The major con-
`siderations in the choice of this hormone
`were its small size and known amino acid
`sequence (1), sensitive radioimmune and
`biological assays (2), and its intrinsic bio-
`logical interest (3). Somatostatin is a tet-
`radecapeptide; it was originally discov-
`ered in ovine hypothalamic extracts but
`subsequently was also found in signifi-
`cant quantities in other species and other
`tissues (3). Somatostatin inhibits the se-
`cretion of a number of hormones, includ-
`ing growth hormone, insulin, and gluca-
`gon. The effect of somatostatin on the se-
`cretion of these hormones has attracted
`attention to its potential therapeutic val-
`ue in acromegaly, acute pancreatitis, and
`insulin-dependent diabetes.
`The overall construction of the soma-
`tostatin gene and plasmid was designed
`to result in the in vivo synthesis of a pre-
`cursor form of somatostatin (see Fig. 1).
`The precursor protein would not be ex-
`
`pected to have biological activity, but
`could be converted to a functional form
`by cyanogen bromide cleavage (4) after
`cellular extraction. The synthetic soma-
`tostatin gene was fused to the lac operon
`because the controlling sites of this oper-
`on are well characterized.
`Given the amino acid sequence of
`somatostatin, one can design from the
`genetic code a short DNA fragment con-
`taining the information for its 14 amino
`acids (Fig. 2). The degeneracy of the
`code allows for a large number of pos-
`sible sequences that could code for the
`same 14 amino acids. Therefore, the
`choice of codons was somewhat arbi-
`trary except for the following restric-
`tions. First, amino acid codons known to
`be favored in E. coli for expression of the
`MS2 genome were used where appropri-
`ate (5). Second, since the complete se-
`quence would be constructed from a
`number of overlapping fragments, the
`fragments were designed to eliminate un-
`desirable inter- and intramolecular pair-
`ing. And third, G*C-rich (guanine-cyto-
`(adenine-
`sine) followed by A*T-rich
`thymine) sequences were avoided since
`they might terminate transcription (6).
`varying
`oligonucleotides,
`Eight
`in
`length from 11 to 16 nucleotides, labeled
`SCIENCE, VOL. 198
`
`Merck Ex. 1068, pg 1527
`
`

`
`in Fig. 2 as A through H, were synthe-
`sized by the triester method (7). In addi-
`tion to the 14 codons for the structural
`information of somatostatin, several oth-
`er features were built into the nucleotide
`sequence. First, to facilitate insertion in-
`to plasmid DNA, the 5' ends have single-
`stranded cohesive termini for the Eco RI
`and Bam HI restriction endonucleases.
`Second, a methionine codon precedes
`the normal NH2-terminal amino acid of
`somatostatin, and the COOH-terminal
`codon is followed by two nonsense co-
`dons.
`In the cloning and expression of the
`synthetic somatostatin gene we used two
`plasmids. Each plasmid has an Eco RI
`substrate site at a different region of the
`,3-galactosidase
`structural
`(see
`gene
`Figs. 3 and 4). The insertion of the syn-
`thetic somatostatin DNA fragment into
`the Eco RI sites of these plasmids brings
`the expression of the genetic information
`in that fragment under control of the lac
`operon controlling elements. After the
`insertion of the somatostatin fragment
`into these plasmids, translation should
`result in a somatostatin polypeptide pre-
`by
`either
`amino
`acids
`ceded
`ten
`(pSOM 1) or by virtually the whole ,3-ga-
`
`E. coli Lac Operon DNA
`
`GENETIC CODE
`
`Chemical
`DNA Synthesis
`
`(
`
`Lac
`
`P 0
`t~AC
`
`'
`
`j3- Gal
`i
`
`l
`
`lAATTC
`
`Somatostatin Gene
`|ATG I GCT GGT TGT AAG AAC TTC TTTr)
`
`- In In '2 PI PI
`
`PW3(RZZ
`
`Plasmid DNA
`
`MAIA
`
`TAG IGAT AGT I TGT GCT TCA CTT TCA GA
`
`I
`
`| In Vivo
`
`NH2
`
`f-Gal
`
`Meet Ala
`
`Gly
`
`Som
`Cys
`Lys Asn
`s
`
`Phe Phe
`
`Trp
`Lys
`
`Thr
`
`Ser' Thr- Phe
`
`HO Cys
`In Vitro
`Cyanogen Bromide
`Cleavage
`
`f- Gal Fragments
`
`+
`
`NH2 ' Ala
`
`Gly * Cys Lys *Asn Phe Phe.
`gI
`S
`Cys * Ser ' Thr - Phe * Thr-
`HO
`Active Somatostatin
`Fig. 1. Schematic outline of the experimental plan. The gene for somatostatin, made by chem-
`ical DNA synthesis, was fused to the E. coli ,8-galactosidase gene on the plasmid pBR322. After
`transformation into E. coli, the chimeric plasmid directs the synthesis of a chimeric protein that
`can be specifically cleaved in vitro at methionine residues by cyanogen bromide to yield active
`mammalian peptide hormone.
`
`Trp
`Lys
`
`Ala
`
`Gly
`
`Cys
`
`Lys
`
`a
`Barn HI
`Eco RI
`(A)
`(D)
`(B)
`(C)
`BaW H
`~
`*i'
`*
`*00 .4
`4&-
`5A AT T C A T G G C T G G T T G TA A G A A C T T C T T T T G G A A GA C T T T CA C T T C G T G T T GA TAG
`G T A C C GA C C AAC A T T C T T GAAGAAAA C C T T C T GAAAG T GAAGC A C AAC T A T C C T A G '
`(H)
`(G)-
`(F)
`(E)
`' '
`No*
`10 "
`0
`
`Asn
`
`Phe Phe
`
`Trp
`
`Lys
`
`Thr
`
`Phe
`
`Thr
`
`Ser
`
`Cys
`
`Stop
`
`Stop
`
`b
`
`DMT
`
`B
`l
`os4L_.
`o0
`
`[om
`
`1
`
`ci
`
`B
`L
`OR
`
`T
`
`+
`
`HO
`
`B
`
`O
`opIl
`Ps
`
`DMT
`
`\
`
`B
`
`OR
`
`2
`
`3
`
`ci
`
`H+
`
` on June 20, 2016
`
`http://science.sciencemag.org/
`
`Downloaded from
`
`Fig. 2. Chemical synthesis of the somatostatin
`gene. (a) Eight oligodeoxyribonucleotides, la-
`beled A through H, were synthesized by the
`modified triester method (7, 23). The codons
`are indicated, and their corresponding amino
`acids are given. The eight fragments were de-
`signed to have at least five nucleotide com-
`plementary overlaps to ensure efficient joining
`by T4 DNA ligase. (b) Recent improvements
`in the synthesis of fully protected trimers,
`which constitute codon blocks and are the
`basic units for building longer oligodeoxyri-
`bonucleotides. With an excess of 1 (2 mmole),
`the coupling reaction with 2 (1 mmole) went
`almost to completion in 60 minutes with the
`aid of a powerful coupling reagent, 2,4,6-
`triisopropylbenzenesulfonyl
`tetrazolide
`(TPSTe, 4 mmole) (2). The 5'-protecting
`group was removed with 2 percent benzene
`sulfonic acid, and the 5'-hydroxyl dimer 5
`could be separated from an excess of 3'-
`phosphodiester monomer 4 by simple solvent
`B = Protected Base
`DMT = 4,4'-dimethoxytrityl
`extraction with aqueous NaHCO3 solution in
`CHC13. The fully protected trimer block was
`prepared successively from the 5'-hydroxyl
`O
`Cl
`11
`11
`dimer 5, 1 (2 mmole), and TPSTe (4 mmole)
`R =-C-<y-OME or -P-O- <-CI
`and isolated by chromatography on silica gel (24). These improvements simplify the purifi-
`I
`cation step and lead to an increase in the overall yields of trimer blocks and to a decrease
`OCH2CH2CN
`in the working time by at least a factor of 2 (21). The eight oligodeoxyribonucleotides then
`were synthesized from the trimers by published procedures (7). The final products, after removal of all protecting groups, were purified by high-
`pressure liquid chromatography on Permaphase AAX (25). The purity of each oligomer was checked by homochromatography on thin-layer
`DEAE-cellulose and also by gel electrophoresis in 20 percent acrylamide (slab) after labeling of the oligomers with [y-32P]ATP in the presence of
`polynucleotide kinase. One major labeled product was obtained from each DNA fragment.
`9 DECEMBER 1977
`
`H +
`
`B
`L
`o'llI
`
`u
`
`1
`
`Y
`
`HO
`
`4
`
`B
`
`B
`O
`HO-T ORmer
`P
`P.-O
`HO
`N0°
`~~~0
`1
`
`Y
`
`5
`
`OR
`
`T
`
`Tnlme
`
`9 DECEMBER 1977
`
`1057~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~15
`1057
`
`Merck Ex. 1068, pg 1528
`
`

`
`0
`
`'-
`0
`
` on June 20, 2016
`
`http://science.sciencemag.org/
`
`Downloaded from
`
`'tI~
`
`t
`
`$414C
`I.
`4) CDEo
`
`co
`
`CD
`_aF < o:0
`
`C.D
`
`X4 FI-
`
`4'~
`
`<I-.
`
`4'
`
`V
`
`0
`
`LIDC) U
`
`U CD
`
`A
`
`W U
`
`0
`
`4
`
`0
`
`v
`
`(D .)
`U
`1
`
`V
`
`<I
`
`0 0
`0 0
`
`:t F
`
`<
`
`> FZc~~~U
`
`LI
`
`~~~~CJDU
`(DC.U
`LI
`
`CD
`
`U
`
`<I
`
`lOS8
`
`SCIENCE, VOL. 198
`
`Merck Ex. 1068, pg 1529
`
`

`
` on June 20, 2016
`
`http://science.sciencemag.org/
`
`Downloaded from
`
`lactosidase subunit structure (pSOM1 1-3).
`The plasmid
`construction scheme
`(Fig. 3) begins with plasmid pBR322, a
`well-characterized cloning vehicle (8).
`The lac elements were introduced to this
`plasmid by insertion of an Hae III restric-
`tion endonuclease fragment (203 nucle-
`otides) carrying the lac promoter, ca-
`tabolite-gene-activator-protein
`binding
`site, operator, ribosome binding site, and
`the first seven amino codons of the /3-ga-
`lactosidase structural gene (9) (Figs. 3
`and 4). The Hae III fragment was de-
`rived from Xplac5 DNA. The Eco RI-
`cleaved pBR322 plasmid, which had its
`termini repaired with T4 DNA polymer-
`ase and deoxyribonucleotide triphos-
`phates, was blunt-end ligated
`to the
`Hae III fragment to create Eco RI termi-
`ni at the insertion points. Joining of these
`Hae III and repaired Eco RI termini gen-
`erate the Eco RI restriction site'(Figs. 3
`and 4) at each terminus. Transformants
`of E. coli RRl (8) with this DNA were
`selected for resistance to tetracycline
`
`(Tc) and ampicillin (Ap) on 5-bromo4-
`chloro-indolylgalactoside (X-gal) medi-
`um (10). On this indicator medium, colo-
`nies constitutive for the synthesis of 8-
`galactosidase by virtue of the increased
`number of lac operators titrating repres-
`sor, are identified by their blue color.
`Two orientations of the Hae III fragment
`are possible, but these were distin-
`guished by the asymmetric location of an
`Hha restriction site in the fragment. Plas-
`mid pBH 10 was further modified to elim-
`inate the Eco RI endonuclease site distal
`to the lac operator (pBH20).
`The eight chemically synthesized oli-
`godeoxyribonucleotides (Fig. 2) were la-
`beled at the 5' termini with [y-32P]ATP
`(adenosine triphophatase) by T4 polynu-
`cleotide kinase and joined with T4 DNA
`ligase. Through hydrogen bonding be-
`tween the overlapping fragments, the
`somatostatin gene self-assembles and
`eventually polymerizes into larger mole-
`cules because of the cohesive restriction
`site termini. The ligated products were
`
`treated with Eco RI and Barm HI restric-
`tion endonucleases to generate the soma-
`tostatin gene (Fig. 2).
`The synthetic somatostatin gene frag-
`ment with Eco RI and Bam HI termini
`was ligated to the pBH20 plasmid, pre-
`viously treated with the Eco RI and
`Bam HI restriction endonucleases and
`alkaline
`phosphatase. The treatment
`with alkaline phosphatase provides a
`molecular selection for plasmids car-
`rying the inserted fragment (11). Ampi-
`cillin-resistant
`transformants
`obtained
`with this ligated DNA were screened for
`tetracycline sensitivity, and several were
`examined for the insertion of an Eco Rl-
`Bam HI fragment of the appropriate
`size.
`Both strands of the Eco RI-Bam HI
`fragments of plasmids from two clones
`were analyzed by a nucleotide sequence
`analysis (12) starting from the Bam HI
`and Eco RI sites. The sequence analysis
`was extended into the lac-controlling ele-
`ments; the lac fragment sequence was in-
`
`Fig. 3 (facing page, left). Construction of recombinant plasmids. Plas-
`mid pBR322 was used as the parental plasmid (8). Plasmid DNA (S jg)
`was digested with the restriction endonuclease Eco RI. The reaction
`was terminated by extraction with a mixture of phenol and chloro-
`form; the DNA was precipitated with ethanol and resuspended in 50
`)zl of T4 DNA polymerase buffer (26). The reaction-was started by the.
`addition of 2 units of T4 DNA polymerase. The reaction (held for 30
`minutes at 3"C) was terminated by extraction with phenol and chloro-
`form and precipitation with ethanol. The XplacS DNA (3 ,ug) was di-
`gested with the endonuclease Hae III (8). The digested pBR322 DNA
`was blunt-end ligated with the Hae III-digested Xplac5 DNA in a final
`volume of 30 ,lA with T4 DNA ligase (hydroxylapatite fraction) (27) in
`20 mM tris-HCI (pH 7.6), 10 mM MgC92, 10 mM dithiothreitol, and
`0.5 mM ATP for 12 hours at 12°C. The ligated DNA mixture was dia-
`lyzed against 10 mM tris-HCI (pH 7.6) and used to transform E. coli
`strain RRI (8). Transformants were selected for tetracycline resist-
`ance (Tc') and ampicillin resistance (Apr) on antibiotic (20 ,ug/ml)
`minimal X-gal (40 .ug/ml) medium (10). Colonies constitutive for the
`synthesis of 8-galactosidase were identified by their blue color. After
`45 independently isolated blue colonies were screened, three of them
`were found to contain plasmids with two Eco RI sites separated by
`approximately 200 base pairs (28). Plasmid pBH1O was shown to carry
`the fragment in the desired orientation, that is, lac transcription going
`into the Tc' gene of the plasmid. Plasmid pBH1O was further modified
`to eliminate the Eco RI site distal to the lac operator and plasmid
`pBH20 was obtained (29). The nucleotide sequence from the Eco RI
`site into the lac-control region of pBH20 (data not shown), was con-
`firmed. This plasmid was used for cloning the synthetic somatostatin
`gene. Plasmid pBH20 (10 ,ug) was digested with endonucleases
`Eco RI and Bam HI and treated with bacterial alkaline phosphatase
`(0.1 unit of BAPF, Worthington), and incubation was continued for 10
`minutes at 65°C. The reaction mixtures were extracted with a mixture
`of phenol and chloroform, and the DNA was precipitated with ethanol
`(30). Somatostatin DNA (50 pJ of a solution containing 4 Ag/ml) was
`ligated
`with the Bam HI-Eco RI,
`alkaline phosphat4se-treated
`pBH20 DNA in a total volume of 50 ,ul with the use of 4 ufnits of T4
`DNA ligase for 2 hours at 22°C (31). In a control experiment,
`Bam HI-Eco RI alkaline phosphatase-treated pBH20 DNA was ligat-
`ed in the absence of somatostatin DNA under similar conditions. Both
`preparations were used to transform E. coli RRI . Transformants were
`selected on minimal X-gal antibiotic plates. Ten Tce transformants
`were isolated. In the control experiment no transformants were ob-
`tained. Four out of the ten transformants contained plasmids with
`both an Eco RI and a Bam HI site. The size of the small Eco RI-
`Bam HI fragment of these recombinant plasmids was in all four in-
`stances similar to the size of the in vitro prepared somatostatin DNA.
`Base sequence analysis (12) revealed that the plasmid pSOMI had the
`9 DECEMBER 1977
`
`desired somatostatin DNA fragment inserted (data not shown). Be-
`cause of the failure to detect somatostatin activity from cultures car-
`rying plasmid pSOMi, a plasmid was constructed in which the soma-
`tostatin gene could be located at the COOH-terminus of the f-galac-
`tosidase gene, keeping the translation in phase. For the construction
`of such a plasmid, pSOMi (50 ,Ag) was digested with restriction en-
`zymes Eco RI and Pst I. A preparative 5 percent polyacrylamide gel
`was used to separate the large Pst I-Eco RI fragment that carries the
`somatostatin gene from the small fragment carrying the lac control
`elements (12). In a similar way plasmid pBR322 DNA (50 ,ug) was
`digested with Pst I and Eco RI restriction endonucleases, and the two
`resulting DNA fragments were purified by preparative electrophoresis
`on a 5 percent polyacrylamide gel. The small iPst I-Eco RI fragment
`from pBR322 (I jug) was' ligated with the large Pst I-Eco RI DNA
`fragment (5 Ag) from pSOMI. The ligated mixture was used to trans-
`form E. coli RRI, and transformants were selected for Apr on X-gal
`medium. Almost all the Apr transformants (95 percent) gave white
`colonies (no lac operator) on X-gal indicator plates. The resulting
`plasmid, pSOM I I, was used in the construction of plasmid pSOM I 1-
`3. A mixture of 5 ,ug of pSOMl I DNA and 5 ,.&g of XplacS DNA was
`digested with Eco RI. The DNA was extracted with a mixture of phe-
`nol and chloroform; the extract was precipitated by ethanol, and the
`precipitate was resuspended in T4 DNA ligase buffer (50 ul) in the
`presence of T4 DNA ligase (1 unit). The ligated mixture was used to
`transform E. ,coli strain RR . Transformants were selected for Apr on
`X-gal plates containing ampicillin and screened for constitutive /3-ga-
`lactosidase production. Approximately 2 percent of the colonies were
`blue (such as pSOM1-1 and 11-2). Restriction enzyme analysis of
`plasmid DNA obtained from these clones revealed that all the plas-
`mids carried a new Eco RI fragment of approximately 4.4 megadal-
`tons, which carries the lac operon control sites and most of the 38-
`galactosidase gene (13, 14). Two orientations of the Eco RI fragment
`are possible, and the asymmetric location of a Hind III restriction in
`this fragment can indicate which plasmids had transcription pro-
`ceeding into the somatostatin gene. The clones carrying plasmids
`pSOM I 1-3, pSOM I 1-5, pSOM I 1-6, and pSOM I 1-7 contained the
`Eco RI fragment in this orientation.
`
`Fig. 4 (facing page, right). Nucleotide sequences of the lac-somatosta-
`tin plasmids. The nucleotide sequence of the lac control elements, 38-
`galactosidase structural gene, and the synthetically derived soma-
`tostatin DNA, are depicted (9, 14, 27) along with the restriction endo-
`nuclease substrate sites. The nucleotide sequence of pSOM I, as de-
`picted, was confirmed (legends to Figs. 3 and 5). The nucleotideo se-
`quence of pSOMI 1-3 was inferred from published data (9, 13, 14, 27).
`The amino acid sequence of somatostatin is italicized. The amino acid
`sequence numbers of /3-galactosidase are in brackets.
`
`1059
`
`Merck Ex. 1068, pg 1530
`
`

`
` on June 20, 2016
`
`http://science.sciencemag.org/
`
`Downloaded from
`
`than 2 ,ug of protein from formic acid-
`bacterial
`treated
`interfered
`extracts
`somewhat by increasing the background,
`but cyanogen bromide cleavage greatly
`reduced this interference. Reconstruc-
`tion experiments showed that somatosta-
`tin is stable in cyanogen bromide-treated
`extracts.
`analysis
`The DNA sequence
`of
`pSOM indicated that the clone carrying
`this plasmid should produce a peptide
`containing somatostatin. However, to
`date all attempts to detect somatostatin
`radioimmune activity from extracts of
`cell pellets or culture supernatants have
`been
`Negative
`unsuccessful.
`results
`were also obtained when the growing
`culture was added directly to 70 percent
`formic acid and cyanogen bromide. We
`calculate that E. coli RRI (pSOMI) con-
`tains less than six molecules of soma-
`tostatin per cell. In a reconstruction ex-
`periment we have observed that exoge-
`is degraded very
`nous somatostatin
`rapidly by E. coli RR1 extracts. The fail-
`ure to find somatostatin activity might be
`accounted for by intracellular degrada-
`tion by endogenous proteolytic
`en-
`zymes.
`If the failure to detect somatostatin ac-
`tivity from pSOMI was due to pro-
`teolytic degradation of the small protein
`(Fig. 4), attachment to a large protein
`might stabilize it. The f3-galactosidase
`structural gene has an Eco RI site near
`the COOH-terminus (13). The available
`data on the amino acid sequence of this
`protein (13, 14) suggested that it would
`be possible to insert the Eco RI-Bam HI
`somatostatin gene into the site and main-
`tain the proper reading frame for the cor-
`rect translation of the somatostatin gene
`(Fig. 4).
`The construction of this plasmid is
`outlined in Fig. 3. The Eco RI-Pst frag-
`ment of the pSOMi plasmid, with the
`lac-controlling element, was removed
`and replaced with the Eco RI-Pst frag-
`ment of pBR322 to produce the plas-
`mid pSOM I. The Eco RI fragment of
`XplacS, carrying the lac operon control
`region and most of the f8-galactosidase
`structural gene, was inserted into the
`Eco RI site of pSOM I. Two orienta-
`tions of the Eco RI lac fragment of
`XplacS were expected. One of these ori-
`entations would maintain the proper
`reading frame into
`the
`somatostatin
`gene, the other would not.
`A number of independently isolated
`clones
`(with
`designations
`plasmid
`pSOM1 1-2 and pSOMI 1-3) were ana-
`lyzed for somatostatin activity, as de-
`scribed above. In constrast to the results
`of experiments with pSOM1, four clones
`(pSOM11-3, 11-5, 11-6, and 11-7) were
`SCIENCE, VOL. 198
`
`tact, and in one case, pSOMI, the nucle-
`otide sequence of both strands were in-
`dependently determined, each giving the
`sequence shown in Fig. 3. In the other
`case, the sequence was identical except
`for a base pair deletion (A*T) at a posi-
`tion equivalent to the junction of the B-C
`oligonucleotides in the original DNA
`fragment. The basis for the deletion is
`unclear.
`The standard radioimmune assays
`(RIA) for somatostatin (2) were modified
`by decreasing the assay volume and by
`using phosphate buffer (Fig.
`6). This
`
`modification proved suitable for the de-
`tection of somatostatin in E. coli ex-
`tracts. Bacterial cell pellets, extracts, or
`cultures were treated overnight in 70 per-
`cent formic acid containing cyanogen
`bromide (5 mg/ml). Formic acid and cy-
`anogen bromide were removed under
`vacuum over KOH before the assay. Ini-
`tial experiments with extracts of E. coli
`strain RRI (the recipient strain) (10) in-
`dicated that less than 10 pg of somatosta-
`tin could easily be detected in the pres-
`ence of 16 ,tg or more of cyanogen bro-
`mide-treated bacterial
`protein. More
`
`Fig. 5. Ligation and acrylamide gel analysis of somatostatin DNA. The 5'-OH termini of the
`chemically synthesized fragments A through H (Fig. 2a) were labeled and phosphorylated sepa-
`rately. Just prior tu the kinase reaction, 25 ,c of [y-32P]ATP (- 1500 c/mmole) (12) was evapo-
`rated to dryness in 0.5-ml Eppendorf tubes. The fragment (5 Ag) was incubated with 2 units of
`T4 DNA kinase (hydroxylapatite fraction, 2500 unit/ml) (26), in 70 mM tris-HCI, pH 7.6, 10 mM
`MgCl2, and 5 mM dithiothreitol in a total volume of 150 ,ul for 20 minutes at 37°C. To ensure
`maximum phosphorylation of the fragments for ligation purposes, 10 ,lI of a mixture consisting
`of 70 mM tris-HCI, pH 7.6, 10 mM MgC92, 5 mM dithiothreitol, 0.5 mM ATP, and 2 units of
`DNA kinase were added, and incubation continued for an additional 20 minutes at 37°C. The
`fragments (250 ng/Al) were stored at -20°C without further treatment. Kinase-treated fragments
`A, B, E, and F (1.25 ,ug each) were ligated in a total volume of 50 Al in 20 mM tris-HCI (pH 7.6),
`10 mM MgCl2, 10 mM dithiothreitol, 0.5 mM ATP, and 2 units of T4 DNA ligase (hydroxyl-
`apatite fraction, 400 unit/ml) (26), for 16 hours at 4°C. Fragments C, D, G, and H were ligated
`under similar conditions. Samples (2 ,A) were removed for analysis by electrophoresis on a 10
`percent polyacrylamide gel and subsequent autoradiography (16) (lanes 1 and 2, respectively).
`The fast migrating material represents unreacted DNA fragments. Material migrating with the
`bromophenol blue dye (BPB) is the monomeric form of the ligated fragments. The slowest
`migrating material represents dimers, which form by virtue of the cohesive ends, of the ligated
`fragments A, B, E, and F (lane 1) and C, D, G, and H (lane 2). The dimers can be cleaved by
`restriction endonuclease Eco RI or Bam HI, respectively (data not shown). The two half mole-
`cules (ligated A + B + E + F and ligated C + D + G + H) were joined by an additional liga-
`tion step carried out in a final volume of 150 IlI at 4°C for 16 hours. A sample (1 JAI) was removed
`for analysis (lane 3). The reaction mixture was heated for 15 minutes at 65°C to inactivate the T4
`DNA ligase. The heat treatment does not affect the migration pattern of the DNA mixture (lane
`4). Enough restriction endonuclease Bam HI was added to the reaction mixture to cleave the
`multimeric forms of the somatostatin DNA in 30 minutes at 37°C (lane 5). After the addition of
`NaCl to a concentration of 100 mM, the DNA was digested with Eco RI endonuclease (lane 6).
`The restriction endonuclease digestions were terminated by phenol-chloroform extraction of
`the DNA. The somatostatin DNA fragment was purified from unreacted and partially ligated
`DNA fragments by preparative electrophoresis on a 10 percent polyacrylamide gel. The band
`indicated with an arrow (lane 7) was excised from the gel, and the DNA was eluted by slicing the
`gel into small pieces and extracting the DNA with elution buffer (0.SM ammonium acetate,
`10 mM MgCI2, 0.1 mM EDTA, and 0.1 percent sodium dodecyl sulfate) overnight at 65°C (12).
`The DNA was precipitated with two volumes of ethanol, centrifuged, redissolved in 200 plI of
`10 mM tris-HCI (pH 7.6), and dialyzed against the same buffer, resulting in a somatostatin DNA
`concentration of 4 ,ug/ml.
`1060
`
`Merck Ex. 1068, pg 1531
`
`

`
` on June 20, 2016
`
`http://science.sciencemag.org/
`
`Downloaded from
`
`entation of the lac operon and the pro-
`duction of somatostatin radioimmune
`activity.
`The design of the somatostatin plas-
`mid predicts that the synthesis of soma-
`tostatin would be under the control of
`the lac operon. The lac repressor gene is
`not included in the plasmid, and the re-
`cipient strain (E. coli RR1) contains the
`wild-type chromosomal lac repressor
`gene, which produces only 10 to 20 re-
`pressor molecules per cell (15). The plas-
`mid copy number (and therefore the
`number of lac operators) is approximate-
`ly 20 to 30 per cell and complete repres-
`sion is impossible. The specific activity
`of somatostatin in E. coli RR1 (pSOMl 1-
`3) was increased by IPTG, an inducer of
`the lac operon (Table I). As expected,
`the level of induction was low, varying
`from 2.4- to 7-fold. In experiment 7
`(Table 1), the a activity (14), a measure
`of the first 92 amino acids of f-galactosi-
`dase, also was induced by a factor of 2.
`
`In several experiments (Table 1 and oth-
`er experi

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket